Biodefence Direct

: Advances in synthetic biology and AI have lowered the bar for creating lethal, novel pathogens in laboratories [2, 19].

: While countries like the Soviet Union once ran massive covert programs to weaponize diseases like smallpox and plague, international treaties (like the Biological Weapons Convention) shifted the focus to purely defensive research [22, 35]. biodefence

Today, the biodefence story is increasingly about the convergence of technologies [19]. : Advances in synthetic biology and AI have

Historically, biodefence emerged from the shadows of offensive biological weapons programs [31, 35]. The Turning Point: Amerithrax In October 2001, just

The story of biodefence is a shift from the horrors of biological warfare to a complex, modern race against pathogens—both natural and man-made . It is a narrative defined by moments of sudden crisis, like the 2001 anthrax attacks , which transformed biodefence into a permanent pillar of national security [11, 21]. The Turning Point: Amerithrax

In October 2001, just weeks after 9/11, letters filled with white powder containing Bacillus anthracis spores were mailed to news offices and U.S. senators [11, 21]. The attack killed five people and hospitalized 17 others, causing widespread panic and forcing a fundamental change in how the world viewed microscopic threats [14, 21]. It proved that biological agents could be used to incite terror and disrupt entire governments [13, 21]. From Offense to Defense